Monthly Archive: July 2016

Seattle Genetics Produces Innovate Cancer Fighting Therapies

Battling cancer is the stock in trade of Seattle Genetics. From its headquarters in Bothell, Washington the biotechnology company has been developing innovative antibody based cancer treatments since 1998. Today they are the industry leader in the creation and commercialization of antibody drug conjugates or ADC. The technology harnesses the ability of monoclonal antibodies to target and deliver agents to kill cancer cells. Some of the strengths of the treatment is that it doesn’t damage the healthy cells, enhances anti-tumor activity and eliminates the toxic effects normally associated with chemotherapy.

Seattle Genetics also partners with a number of companies to give people around the world access to their groundbreaking therapies. Currently the ADC treatment they have developed is used in 60 countries. Some of the companies with which they have collaborated to market their antibody-based therapies include Takeda Pharmaceutical Company, Pfizer, Genentech, GlaxoSmithKline and AbbVie. This is important because their ADC therapy is one of the first new cancer treatments in over 30 years. Seattle Genetics also has a number of very promising therapies in their product pipeline

Dr. Clay Siegall, Co-Founder, CEO, and President of Seattle Genetics, has played a very important role in the company’s amazing growth. An innovative scientist long focused on rigorous research combined with drug development and testing, he built the company on scientific innovation. He also secured $1.2 billion in financing and FDA approval for ADCETRIS, their proprietary ADC product. Dr. Clay Siegall has been involved in cancer research for many years. Before co-founding Seattle Genetics, he worked with the National Institutes of Health, the National Cancer Institute and Bristol-Myers Squibb Pharmaceutical Research Institute.

After earning a University of Maryland undergrad degree in Zoology and a Genetics doctorate from George Washington University, he’s had his work published in more than 70 publications. He is a member of numerous biotech company boards and holds 15 patents. Dr. Siegall has also won several awards for his work on cancer research. At Seattle Genetics he leads a staff that includes over 800 employees that are passionate about trying to find new ways to help people living with cancer.

Learn more about Clay Siegall

http://www.ultragenyx.com/about/board/siegall/

http://www.pegsummit.com/uploadedFiles/PEGS/Agenda/15/PEGS-Interview-Siegall.pdf

Laidlaw Continues to Help Others With Personal Investments

Relmada Therapeutics is a clinical-stage business that creates therapies for chronic pain. The U.S. District Court has issued a restraining order to Laidlaw and Company and to Matthew Eitner and James Ahern for offering false and misleading materials. A previous lawsuit from Relmada against Messrs and Laidlaw led to the court issued response. Laidlaw is an investment firm that previously assisted Relmada. The principals of Laidlaw led to the U.S. financial regulations being violated, which led to the customer complains and monetary penalties.

Sergio Traversa, the Chief Executive of Relmada is very pleased with the Court recognizing the importance of their request and the issuance of an order. They would prefer the focus of attention would be on Relmada’s products and the development of BuTab. He does not believe that the Company to Laidlaw would be value destructive. He believes that the interests of Laidlaw are different from those of the Relmada stockholders. He will continue to take action and protect his company and the Relmada stockholders.

Laidlaw and Company has over 170 years of banking experience. They focus on international and domestic companies. They have over 150 companies working for them in Europe and the United States. They focus on a strong work ethic and enjoy thinking outside of the box. Laidlaw and Company has the ability to help emerging businesses raise capital through retail sales and gives corporate clients the ability to grow financially.

They are a healthcare driven investment company that focuses on helping senior professionals use their experience with an independent firm. They strive to have a hands-o management team that offers positive solutions. They serve clients on a global basis and continue to grow a positive reputation for themselves.

Original Source:

https://www.thestreet.com/story/13394818/1/us-federal-court-issues-temporary-restraining-order-against-laidlaw-company-and-its-principals-matthew-eitner-and-james-ahern.html

Can Devco Change The Face Of New Jersey?

Devco is more than capable fo changing the face of New Jersey according to the Press of Atlantic City. There are a lot of cities that need to change around communities that are just not very functional, and they need to bring jobs to the area while also cutting down on crime. They will also make a lot of tax money that is going to help pay for things like social services. It is very important for every single community in New Jersey to get a loan from Devco so that they can start planning how they are going to change their fortunes for the future.

The people who are most invested in these community projects are the people from Devco. They do offer a plan for every loan, and they send in professionals who are going to help the city learn how to turn around a place that has been blighted. Blight in cities in New Jersey can be very bad, and it takes away jobs and good places to live for the people of the area. The communities that get these new developments are going to be able to host people with better jobs while other new businesses come calling.

The businesses that are growing in smaller areas of New Jersey are going to be able to have jobs for the people that never had them, and then those people will have money to live in better housing. They might even start their own businesses, and that will put even more money back into the community. It helps to make sure that the community has a strong foundation that people can count on. They have been fighting against problems in their communities, but now a new hotel or casino will create tax revenue that will pay for the loans from Devco.

 

Kevin Seawright Turns Dreams of Home Ownership into Reality

Kevin Seawright and RPS Solutions LLC are seeking to provide affordable housing in the City of Baltimore. RPS Solutions was founded in 2015 by Seawright with the vision of providing affordable housing to strengthen communities. Seawright hopes Baltimore’s current home ownership level of 48.3% will grow significantly due to his efforts. This will not only strengthen neighborhoods but also provide economic benefits and a more vibrant community. RPS Solutions connects lenders to individuals seeking home financing. They also manage assets and construction and renovation projects. RPS is currently developing properties in Baltimore and these surrounding areas: Carney, Cedonia, Belair-Edison, and West Edmondale. Seawright believes that home ownership is the most important aspect of strategic wealth development.

Seawright comes with over 13 years of experience with governmental and financial responsibilities. He has been the Managing Fiscal Officer of Baltimore’s Commission on Aging and Retirement. After that, he worked as Finance Director of the Homeless Services within the Department of Housing and Community Development. He moved on to become the Chief Financial Officer and Facilities Officer of the Department of Recreation and Parks. Next he served as a Deputy Chief Operating Officer in the education sector. From 2014 to 2016 he served as the Vice President and Chief Financial Officer of the Newark Community Economic Development Corporation, which serves as a catalyst for growth. During his career, Seawright has been responsible for over $400M in city, state, federal, capital, private and bond funds. He has also overseen over $600M in capital construction in education facilities.

Seawright graduated from Almeda University in 2006 with a Master’s in Accounting. He has been a member of the American Society for Public Administration, the National Forum for Black Public Administrators, and the National Association of Black Accountants. He has served as an Advisory Board Member of for the Babe Ruth Museum. Seawright graduated from the Notre Dame Mendoza School of Business for Executive Leadership program in 2015. He has also received numerous awards for his outstanding financial responsibilities including being a Met Life recipient of the Bridges to the Future Award for operational and financial professionalism.  Be sure to follow Kevin on SoundCloud.